@USSLiberty Personally my take is to always start on that low dose and see how you feel after doing it a couple times. Then go up if you aren’t feeling the desired effects. My bunny reacts completely different to my results. This is a marathon of life not a sprint, although I have a tendency to want to try more so I bought my peptides refrigerator this week and have probably a 18-24 month plan…

@researchcat i made a post under the mot-c dosing topic. https://community.peptidecritic.com/post/2819 Based on half life’s, dosing Mot-C then dose NAD+ 8 hrs later would get full benefits of both without overlap.

@brithus said in ARA 290: @Randy I second this suggestion! Cartalax has helped my neck and back issues immensely. I had C4,5,6 fused in my neck over 10 years ago and now the vertabrae above and below are wearing out due to the added stress of compensating for the fusion. After about 3 weeks of Cartalax, pain level is 80-90%less I have a monkey in my lab who has old rotator cuff injuries, had surgery years ago, started having a lot of pain, couldn't raise arms above head without extreme pain. Began researching cartalax a month ago along with BP and TB. Fast forward to today, pain has lessened a good 50+% that's good progress!

@PeptideEd Right now I’m on a M W F schedule. Will taper down to weekly.

@ymbrown1976-gmail-com this is where I’ve always gotten my glutathione from. Currently a case of 10 is $60. $30 shipping no matter what you order. Usually shipped with FedEx express. I’ve received orders in 3 days, and sometimes 3 weeks because it sat in port for two weeks. It is Korean pharma grade. https://www.acecosm.com/categories/health-booster/ki-glutaone-inj-glutathione-1200mg

I started at 3mg with with the intention of ending up at 4mg, so that was my plan to gradually move up. I'm on Day 2, so take that for what it's worth, but I have no stinging sensation that others talk about with GLOW or GHK-CU. This is supposed to be due to the anti-inflammation properties of KPV. If I had it to do over, I'd use a 5ml vial and add a total of 4ml of BAC so the units are slightly higher. For some reason, it seems like there is more resistance than I antipicated to push with my pen. The concentration of the solution may be a little viscous for an 11unit push. Thinning it out with a little more BAC could help.

@MyB Im a itchy boy myself. I can tell you bpc/tb4 always cause me to get itchy by day 3/4. Its well documented on other forums and reddit. Kpv can even push me into histamine issues if im doing too much for too long. Plain GHK is fine and im back to 6mg in the morning. I was doing 10mg but it was becoming too painful.

I just ordered 3 Gansulin pens, i cant wait to add SS-31 for when im on the higher dose.

@randy where are you getting tb4?

@Ed-Warnicke oh, thank you! I will!

I have not, but I'll be purchasing it next time I have to purchase bpc. I need to get a few inserts for my storage container, nexpha is gonna make my freezer look like that house in Vegas.

Man, I thought 5 was a lot!

Copper went in with no pain today I reconstituted a 100mg with 9ml of bac water and filled 3 pen cartridges that I also filtered. The videos really help and after a month of researching, I see how you can get hooked on feeling better. If it wasn’t for the pens, I wouldn’t be researching. Thanks Randy! I just received my Gansulin Pen

So couple of factors, Price and are you willing the 3 shots separately. I use all 3 separately however im shifting to KLOW and adding the Cartalax and up dose on TB 2x a week

For research use only. Not medical advice. Overview TB4/TB-500 is a synthetic peptide that corresponds to the active region of thymosin beta-4, a naturally occurring protein involved in tissue repair, regeneration, angiogenesis, and cellular migration. It is commonly used in research models focused on soft-tissue recovery, tendon/ligament healing, and systemic repair pathways. The most common approach is once-daily subcutaneous dosing with gradual escalation. Daily Dosing Protocol Standard Daily Range 500–1,000 mcg once daily This matches the typical systemic dose range used in most animal and translational research models. Titration Schedule Weeks 1–2 500 mcg daily Conservative starting point to assess tolerability. Weeks 3–4 600 mcg daily Weeks 5–8 750 mcg daily This is the most common “working dose” for injury-repair protocols. Upper-end daily dose used for intensive repair phases. Timing Once daily, at a consistent time. Many researchers prefer evening dosing to align with recovery periods, but timing is flexible. Cycle Length Typical TB4/TB-500 research cycles: 4-8 weeks, depending on severity and type of tissue-repair model 4 weeks off before repeating Some injury models include a “loading phase” (daily), then “maintenance phase” (2–3×/week), but daily remains the standard for systemic use Common Research Notes TB4/TB-500 distributes systemically and does not require localized injection. Reported effects include improved mobility, reduced inflammation, accelerated soft-tissue recovery, and enhanced healing timelines. Often stacked with BPC-157 for synergistic repair effects—TB-500 for systemic repair, BPC-157 for localized or gastrointestinal pathways. Mild fatigue or warmth at the injection site may occur early in use.

For research use only. Not medical advice. Overview BPC-157 is a synthetic 15–amino-acid peptide studied for potential effects on tissue repair, inflammation modulation, and gastrointestinal protection. Human clinical evidence is still limited, so researchers rely on conservative dosing patterns derived from preclinical data. Subcutaneous administration is the most common route in systemic research models. Daily Dosing Protocol (Subcutaneous) Standard Daily Range 200–600 mcg once daily Escalate gradually to assess individual response and tolerance. Titration Schedule Weeks 1–2 200 mcg daily Useful as a gentle introduction, particularly when monitoring sensitivity. Weeks 3–4 400 mcg daily Represents the common working dose for generalized healing or recovery-focused protocols. Weeks 5–8+ 600 mcg daily Higher end of typical daily research use; often maintained for prolonged tissue-repair goals. Timing Once daily, at any consistent time. Some researchers prefer morning fasted dosing; others use evening to complement recovery protocols — timing is flexible. Cycle Length Standard BPC-157 research cycles: 4–8 weeks, depending on the model Optional 2–4 week break before repeating Shorter cycles may be used for acute-injury research models Chronic continuous use is less common due to limited long-term human data. Common Research Notes BPC-157 is generally well tolerated, though individual sensitivity varies. Some subjects report improvements in soft-tissue recovery, joint comfort, or GI stability within 1–3 weeks. Effects may plateau after several weeks, which is why cycles often cap at 8 weeks. Some researchers combine BPC-157 with TB-500 or GHK-Cu for injury-specific protocols.